Cargando…

Neoadjuvant therapy in pancreatic cancer: a systematic review and meta‐analysis of prospective studies

There is a strong rationale and many theoretical advantages for neoadjuvant therapy in pancreatic cancer (PC). However, study results have varied significantly. In this study, a systematic review and meta‐analysis of prospective studies were performed in order to evaluate safety and effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Han‐Xiang, Xu, Jian‐Wei, Wu, Dong, Wu, Zhi‐Yang, Wang, Lei, Hu, San‐Yuan, Zhang, Guang‐Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463082/ https://www.ncbi.nlm.nih.gov/pubmed/28544758 http://dx.doi.org/10.1002/cam4.1071

Ejemplares similares

Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer
por: Desai, Neelam V, et al.
Publicado: (2015)

Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
por: Ni, Chao, et al.
Publicado: (2020)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer
por: Zhan, Han-xiang, et al.
Publicado: (2015)

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial
por: Zhao, Qun, et al.
Publicado: (2020)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
por: Chang, Hui, et al.
Publicado: (2019)

Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
por: Li, Yongzheng, et al.
Publicado: (2022)

Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
por: Yokose, Takahiro, et al.
Publicado: (2020)

Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study
por: Yuan, Yonggang, et al.
Publicado: (2020)

Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer
por: Pang, Xiaolin, et al.
Publicado: (2021)

Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection
por: Wolfe, Adam R., et al.
Publicado: (2020)

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
por: Lim, Li Yan, et al.
Publicado: (2016)

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2016)

A blind randomized validated convolutional neural network for auto‐segmentation of clinical target volume in rectal cancer patients receiving neoadjuvant radiotherapy
por: Wu, Yijun, et al.
Publicado: (2021)

The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Predicted the P2RX7 rs3751143 polymorphism is associated with cancer risk: a meta-analysis and systematic review
por: Wang, Bi-jun, et al.
Publicado: (2021)

CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study
por: Li, Yan-Ling, et al.
Publicado: (2023)

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
por: Katz, Matthew H G, et al.
Publicado: (2023)

Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Hoendervangers, S., et al.
Publicado: (2020)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta‐analysis
por: Ding, Zuo‐you, et al.
Publicado: (2019)

Age comorbidity scores as risk factors for 90‐day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population‐Based Study
por: Shia, Ben‐Chang, et al.
Publicado: (2019)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose–response meta-analysis
por: Wu, Guanghai, et al.
Publicado: (2020)

Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization
por: Chen, Zhen‐Xin, et al.
Publicado: (2019)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy
por: Wu, Miao‐Fang, et al.
Publicado: (2019)

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status
por: Zhou, Juan, et al.
Publicado: (2016)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer
por: Prakash, Ipshita, et al.
Publicado: (2022)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma
por: Li, Ge, et al.
Publicado: (2020)

Predictive value of β-catenin in bladder cancer: a systematic review and meta-analysis
por: Ren, Jin, et al.
Publicado: (2020)

Prognostic significance of the systemic immune‐inflammation index in pancreatic carcinoma patients: a meta-analysis
por: Li, Xiaocheng, et al.
Publicado: (2021)

The effect of LTA gene polymorphisms on cancer risk: an updated systematic review and meta- analysis
por: Li, Jingdong, et al.
Publicado: (2020)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies
por: Xia, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i6v0b7d7ap4oc1bh3pp4ftch6m